Mark Lowdell's Insider Trades & SAST Disclosures
Mark Lowdell's most recent trade in INmune Bio Inc was a trade of 140,000 Option (right to buy) done . Disclosure was reported to the exchange on Dec. 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark Lowdell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 140,000 | 140,000 | - | - | Option (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 100,000 | 100,000 | - | - | Option (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Apr 2024 | 14,423 | 14,423 | - | - | Common Stock Warrants (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.32 per share. | 19 Apr 2024 | 14,423 | 1,510,806 (14%) | 0% | 8.3 | 119,999 | Common Stock |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 104,000 | 104,000 | - | - | Option (right to buy) | |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 8.43 per share. | 21 Mar 2022 | 23,590 | 1,496,383 (13%) | 0% | 8.4 | 198,864 | Common Stock |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 03 Nov 2021 | 701 | 1,472,793 (13%) | 0% | 20 | 14,020 | Common Stock |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 27 Oct 2021 | 2,357 | 1,473,494 (13%) | 0% | 20 | 47,140 | Common Stock |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 22 Oct 2021 | 400 | 1,475,851 (13%) | 0% | 20 | 8,000 | Common Stock |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.19 per share. | 07 Jul 2021 | 24,150 | 1,476,251 (13%) | 0% | 20.2 | 487,589 | Common Stock |
| INmune Bio Inc | Mark Lowdell | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 07 Jul 2021 | 5,850 | 1,500,401 (13%) | 0% | 20.0 | 117,117 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges